Mp36-06 using aorta-lesion-attenuation-difference (alad) on preoperative contrast-enhanced ct scan to differentiate between malignant and benign renal tumors

To evaluate the ability of Aorta-Lesion-Attenuation-Difference (ALAD) to differentiate malignant renal tumors from renal oncocytomas.

Source: The Journal of Urology - April 1, 2018 Category: Urology & Nephrology Authors: Joseph Grajo, Russell Terry, Justin Ruoss, Blake Noennig, Jonathan Pavlinec, Shahab Bozorgmehri, Paul Crispen, Li-Ming Su Tags: Kidney Cancer: Epidemiology & Evaluation/Staging II Source Type: research